Laboratoire Hra Pharma competitive analysis

Latest publications and patents of Laboratoire Hra Pharma New

Explore the latest publications and patents granted to Laboratoire Hra Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Laboratoire Hra Pharma

Oct 2, 2019Use Of Ulipristal Acetate For Treating Uterine FibroidsRevoked
Jan 31, 2018Solid Dispersion Of A Selective Modulator Of The Progesterone ReceptorNo Opposition Filed Within Time Limit

Explore Laboratoire Hra Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2019Use Of Ulipristal Acetate For Treating Uterine Fibroids2

Latest PTAB cases involving Laboratoire Hra Pharma

Discover the latest PTAB cases involving Laboratoire Hra Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratoire Hra Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
LABORATOIRE HRA PHARMA - 2 - - Non-Active
HOFFMANN EITLE147 - - - Highly Aggressive
WITTKOPP10 - - - Highly Aggressive